• Plk1 Control of p31comet in Checkpoint Exit

  2026-10-07

  The reference study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. Its evidence links Plk1-dependent phosphorylation of p31comet at S102 with suppression of TRIP13-assisted Mad2 release, offering a mechanistic explanation for how cells limit premature checkpoint inactivation.

• Polygodial and TRPA1: Research Context and Evidence

  2026-10-07

  A source-grounded overview of Polygodial as a reported TRPA1 channel activator, its relevance to sensory signaling and epithelial inflammation, and the limitations of applying current nasal-cell findings to this compound.

• Gefitinib (ZD1839) in Gastric Cancer Assembloids

  2026-10-06

  Explore how Gefitinib (ZD1839) can be interpreted in patient-derived gastric cancer assembloids, where stromal context reshapes EGFR signaling, drug response, and resistance evidence. This article distinguishes direct findings from translational hypotheses and defines the model’s applicability boundaries.

• GLP-1 (9-36) Amide: From Antagonist to Insight

  2026-10-06

  GLP-1 (9-36) amide can serve as a mechanistic probe for context-dependent GLP-1 receptor pharmacology. This thought-leadership analysis connects the peptide’s reported antagonist positioning with evidence that glucagon can signal through GLP-1R under specific experimental contexts, while distinguishing direct findings from translational hypotheses and clinical implications.

• DNA Frameworks Improve Enzymatic DNA Synthesis

  2026-10-05

  A 2025 Advanced Science study reports that tetrahedral DNA nanostructures can organize primer presentation at a nanoscale interface, improving enzyme accessibility, catalytic behavior, and sequence fidelity in enzymatic oligonucleotide synthesis. The work links structural control with a reported 96.82% stepwise yield for a 60-nucleotide information-storage sequence, while leaving important questions about generality and scale unresolved.

• Halazone: From Disinfection to Ion-Channel Evidence

  2026-10-05

  Halazone is more than a water disinfection agent: it is also a chemically informative probe of sodium-current inactivation. This article separates established findings from tentative mechanisms and defines the evidence boundaries for antimicrobial resistance research and neurophysiology.

• Levofloxacin: Reading Resistance Across Scales

  2026-10-04

  Levofloxacin connects bacterial DNA replication biology with interpretable resistance and tissue-model evidence. This article examines how the Guangdong CREC study reframes levofloxacin susceptibility as one layer within a broader genotype, plasmid, and clinical surveillance framework.

• Carbapenemase Transmission in CREC: Guangdong Evidence

  2026-10-03

  Chen et al. integrated gene-location analysis, antimicrobial susceptibility testing, transfer assays, mobile-element profiling, and strain typing to characterize carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The findings point to frequent plasmid-associated blaNDM-1, substantial multidrug resistance, and strong dissemination potential, while also showing why laboratory transfer and typing results should not be equated directly with hospital-wide transmission.

• Pleuromutilin Binding at the Ribosomal PTC

  2026-10-02

  The 2006 study by Long and colleagues combined chemical footprinting, ribosomal structural information, and an Escherichia coli L3 mutant to clarify how pleuromutilin antibiotics occupy the peptidyl transferase center. Its central finding is that the conserved mutilin core anchors Tiamulin-class compounds, whereas side-chain contacts help determine rRNA remodeling and resistance behavior, providing a rational framework for derivative design.

• (S,S)-Nanaomycin A: DNMT3B Assay Guide

  2026-10-01

  Explore how (S,S)-Nanaomycin A can be used to interrogate DNMT3B-driven neuroendocrine plasticity in prostate cancer. This guide translates recent mechanistic findings into a state-aware experimental framework for distinguishing lineage reprogramming from nonspecific cytotoxicity.

• Prednisone: Mechanism, Evidence, and Bench Workflow

  2026-10-01

  Prednisone is a synthetic corticosteroid used in research on lymphocyte regulation, apoptosis, neurodegeneration, and corticosteroid pharmacology. Product-specific evidence describes G1-phase arrest, reduced IL-2 signaling, and dose- and time-dependent apoptosis in activated human peripheral blood lymphocytes.

• Doxorubicin Hydrochloride Research Workflow

  2026-09-30

  Build more informative cancer chemotherapy research workflows with Doxorubicin hydrochloride, from dose–response and apoptosis assays to mechanistic cardiotoxicity models. This guide connects practical assay design with a mouse study showing how oxidative stress, ferroptosis-related injury, and cardiac function can be evaluated together.

• Homer1a–Caspase-6 Signaling in Inflammatory Pain

  2026-09-30

  The reference study identifies a Homer1a/caspase-6/tumor necrosis factor-alpha axis that links synaptic signaling with microglial inflammation and thermal hypersensitivity. Pharmacologic inhibition and Homer1a overexpression both reduced pain-related outcomes in rats, supporting caspase-6 as a mechanistic node while leaving important questions about cell specificity, chronic pain, and translation unresolved.

• Spatially Concentrated ABEs Correct PLP1 Mutations

  2026-09-29

  The 2026 Nucleic Acids Research study introduces spatially concentrated adenine base editors that improve editing in oligodendrocytes by locally enriching TadA* at genomic targets rather than simply increasing catalytic activity. An AAV-compatible editor corrected PLP1 A243V, improved Plp localization, and rescued myelination-associated phenotypes, providing a preclinical framework for Pelizaeus–Merzbacher disease research.

• Plk1 Regulation of p31comet Checkpoint Disassembly

  2026-09-29

  The reference study identifies Polo-like kinase 1 (Plk1) as a direct regulator of p31comet-mediated mitotic checkpoint complex disassembly. By phosphorylating p31comet at S102, Plk1 suppresses TRIP13-dependent Mad2 release and may prevent premature checkpoint inactivation during active mitosis.

8037 records 1/536 page Next 12345 下5页 Last page